NeuroOne Medical Technologies Corporation (NMTC)
USD 0.74
(-6.41%)
USD 0.74
(-6.41%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 184.4 Thousand USD | -9.12% |
| 2022 | 202.89 Thousand USD | -35.73% |
| 2021 | 315.67 Thousand USD | -76.07% |
| 2020 | 1.31 Million USD | 0.0% |
| 2019 | - USD | -100.0% |
| 2018 | 1.67 Million USD | -30.75% |
| 2017 | 2.42 Million USD | 779.86% |
| 2016 | 275.19 Thousand USD | 1920.68% |
| 2015 | 13.61 Thousand USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 28 Thousand USD | 64.71% |
| 2012 | 17 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 121.89 Thousand USD | -20.7% |
| 2024 Q3 | 290.09 Thousand USD | 137.98% |
| 2024 Q1 | 153.72 Thousand USD | -16.64% |
| 2023 Q3 | 214.48 Thousand USD | -12.09% |
| 2023 Q4 | 184.4 Thousand USD | -14.03% |
| 2023 FY | 184.4 Thousand USD | -9.12% |
| 2023 Q1 | 272.4 Thousand USD | 34.26% |
| 2023 Q2 | 243.98 Thousand USD | -10.43% |
| 2022 FY | 202.89 Thousand USD | -35.73% |
| 2022 Q1 | 288.38 Thousand USD | -8.64% |
| 2022 Q4 | 202.89 Thousand USD | -12.55% |
| 2022 Q3 | 232.01 Thousand USD | -10.99% |
| 2022 Q2 | 260.66 Thousand USD | -9.61% |
| 2021 Q3 | 269.41 Thousand USD | -5.22% |
| 2021 Q1 | 298.32 Thousand USD | -77.39% |
| 2021 Q2 | 284.23 Thousand USD | -4.72% |
| 2021 FY | 315.67 Thousand USD | -76.07% |
| 2021 Q4 | 315.67 Thousand USD | 17.17% |
| 2020 Q4 | 1.31 Million USD | -81.29% |
| 2020 Q1 | 5.53 Million USD | 0.0% |
| 2020 Q2 | 5.26 Million USD | -4.88% |
| 2020 FY | 1.31 Million USD | 0.0% |
| 2020 Q3 | 7.05 Million USD | 34.09% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q3 | - USD | -100.0% |
| 2019 Q1 | 2.18 Million USD | 30.36% |
| 2019 Q2 | 229 Thousand USD | -89.52% |
| 2019 FY | - USD | -100.0% |
| 2018 FY | 1.67 Million USD | -30.75% |
| 2018 Q4 | 1.67 Million USD | -51.58% |
| 2018 Q3 | 3.46 Million USD | 20.5% |
| 2018 Q2 | 2.87 Million USD | 18.7% |
| 2018 Q1 | 2.42 Million USD | 45.52% |
| 2017 Q1 | 275.19 Thousand USD | 0.0% |
| 2017 Q2 | 524.67 Thousand USD | 90.65% |
| 2017 Q3 | - USD | -100.0% |
| 2017 Q4 | 1.66 Million USD | 0.0% |
| 2017 FY | 2.42 Million USD | 779.86% |
| 2016 Q1 | 13.61 Thousand USD | 45.67% |
| 2016 FY | 275.19 Thousand USD | 1920.68% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | -100.0% |
| 2016 Q2 | 17.63 Thousand USD | 29.48% |
| 2015 FY | 13.61 Thousand USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | 9349.00 USD | 70.48% |
| 2015 Q3 | 5484.00 USD | 0.0% |
| 2015 Q1 | - USD | -100.0% |
| 2014 Q2 | - USD | -100.0% |
| 2014 Q1 | 28 Thousand USD | 5.66% |
| 2014 FY | - USD | -100.0% |
| 2014 Q4 | 17.21 Thousand USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q4 | 26.5 Thousand USD | 6.0% |
| 2013 FY | 28 Thousand USD | 64.71% |
| 2013 Q2 | 21 Thousand USD | 23.53% |
| 2013 Q1 | 17 Thousand USD | 6.25% |
| 2013 Q3 | 25 Thousand USD | 19.05% |
| 2012 FY | 17 Thousand USD | 0.0% |
| 2012 Q3 | 16 Thousand USD | 0.0% |
| 2012 Q4 | 16 Thousand USD | 0.0% |
| 2012 Q2 | 16 Thousand USD | 0.0% |
| 2012 Q1 | - USD | -100.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | 16 Thousand USD | 0.0% |
| 2011 Q3 | 16 Thousand USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 99.966% |
| Nemaura Medical Inc. | 20.03 Million USD | 99.079% |
| NeuroPace, Inc. | 72.39 Million USD | 99.745% |
| LENSAR, Inc. | 2.3 Million USD | 92.014% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 97.49% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | 88.439% |
| Apyx Medical Corporation | 38.5 Million USD | 99.521% |
| Cutera, Inc. | 431.91 Million USD | 99.957% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 98.82% |
| BioSig Technologies, Inc. | 452 Thousand USD | 59.204% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 99.53% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.989% |
| Axonics, Inc. | 27.61 Million USD | 99.332% |
| IRIDEX Corporation | 2.74 Million USD | 93.285% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 99.767% |
| TELA Bio, Inc. | 42.78 Million USD | 99.569% |
| Tivic Health Systems, Inc. | 369 Thousand USD | 50.027% |
| RxSight, Inc. | 3.01 Million USD | 93.878% |
| Align Technology, Inc. | 96.96 Million USD | 99.81% |
| INVO Bioscience, Inc. | 8.68 Million USD | 97.876% |
| electroCore, Inc. | 626 Thousand USD | 70.543% |
| Telesis Bio, Inc. | 34.38 Million USD | 99.464% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 98.205% |
| Quipt Home Medical Corp. | 98.94 Million USD | 99.814% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 99.365% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 92.147% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 98.791% |
| Dynatronics Corporation | 6.68 Million USD | 97.243% |
| Modular Medical, Inc. | 1.19 Million USD | 84.504% |
| ReShape Lifesciences Inc. | 262 Thousand USD | 29.618% |
| Talis Biomedical Corporation | 19.66 Million USD | 99.062% |
| PetVivo Holdings, Inc. | 1.36 Million USD | 86.491% |
| InMode Ltd. | 9.01 Million USD | 97.955% |
| Envoy Medical, Inc. | 404 Thousand USD | 54.356% |
| Bruker Corporation | 1.37 Billion USD | 99.987% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -223.509% |
| DexCom, Inc. | 2.59 Billion USD | 99.993% |
| Nexalin Technology, Inc. | 4463.00 USD | -4031.75% |
| PAVmed Inc | 48.72 Million USD | 99.622% |
| Viveve Medical, Inc. | 5.34 Million USD | 96.553% |
| Cerus Corporation | 95.99 Million USD | 99.808% |
| Movano Inc. | 252 Thousand USD | 26.825% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 99.444% |
| Nexalin Technology, Inc. | 4463.00 USD | -4031.75% |
| IceCure Medical Ltd | 599 Thousand USD | 69.215% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 99.956% |
| enVVeno Medical Corporation | 1.4 Million USD | 86.847% |
| 908 Devices Inc. | 5.94 Million USD | 96.898% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 98.677% |
| Orthofix Medical Inc. | 134.19 Million USD | 99.863% |
| Surmodics, Inc. | 29.4 Million USD | 99.373% |
| Nuwellis, Inc. | 981 Thousand USD | 81.203% |
| Outset Medical, Inc. | 136.18 Million USD | 99.865% |
| Venus Concept Inc. | 79.69 Million USD | 99.769% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 99.858% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 99.738% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 97.804% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | 80.39% |
| Inogen, Inc. | 21.92 Million USD | 99.159% |
| IRadimed Corporation | 2.04 Million USD | 90.974% |
| MaxCyte, Inc. | 18.74 Million USD | 99.016% |
| Pulmonx Corporation | 41.42 Million USD | 99.555% |
| PAVmed Inc. | 48.72 Million USD | 99.622% |
| iCAD, Inc. | 461 Thousand USD | 60.0% |
| OrthoPediatrics Corp. | 23.76 Million USD | 99.224% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | 90.764% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | 62.52% |
| SI-BONE, Inc. | 38.99 Million USD | 99.527% |
| Semler Scientific, Inc. | 70 Thousand USD | -163.429% |
| Beyond Air, Inc. | 17.83 Million USD | 98.966% |
| FONAR Corporation | 41.67 Million USD | 99.558% |
| AxoGen, Inc. | 69.29 Million USD | 99.734% |
| Biotricity, Inc. | 23.87 Million USD | 99.228% |
| Cytosorbents Corporation | 18.31 Million USD | 98.993% |
| ZimVie Inc. | 521.92 Million USD | 99.965% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 99.634% |
| Inari Medical, Inc. | 32.04 Million USD | 99.425% |
| UFP Technologies, Inc. | 46.03 Million USD | 99.599% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | 90.764% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | 93.996% |
| Sight Sciences, Inc. | 35.41 Million USD | 99.479% |
| Insulet Corporation | 1.44 Billion USD | 99.987% |
| Profound Medical Corp. | 7.9 Million USD | 97.666% |
| Bioventus Inc. | 409.47 Million USD | 99.955% |
| InspireMD, Inc. | 1.59 Million USD | 88.439% |
| BrainsWay Ltd. | 471 Thousand USD | 60.849% |
| BIOLASE, Inc. | 17.91 Million USD | 98.97% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | 82.207% |
| Tenon Medical, Inc. | 1.17 Million USD | 84.28% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 81.597% |
| CVRx, Inc. | 30.61 Million USD | 99.398% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.992% |
| Sintx Technologies, Inc. | 4.24 Million USD | 95.656% |
| Acutus Medical, Inc. | 38.47 Million USD | 99.521% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | 90.757% |
| NanoVibronix, Inc. | 5000.00 USD | -3588.0% |
| Quanterix Corporation | 41.46 Million USD | 99.555% |
| LivaNova PLC | 640.4 Million USD | 99.971% |
| Co-Diagnostics, Inc. | 2.99 Million USD | 93.834% |
| Varex Imaging Corporation | 469.5 Million USD | 99.961% |
| Vivani Medical, Inc. | 20.69 Million USD | 99.109% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 92.147% |
| Sensus Healthcare, Inc. | 783 Thousand USD | 76.45% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.98% |
| TransMedics Group, Inc. | 515.94 Million USD | 99.964% |
| ReWalk Robotics Ltd. | 1.9 Million USD | 90.31% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | 23.446% |
| Spectral AI, Inc. | 1.28 Million USD | 85.694% |
| Hyperfine, Inc. | 185 Thousand USD | 0.324% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 99.904% |
| Biomerica, Inc. | 785 Thousand USD | 76.51% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 58.975% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | 50.176% |
| Silk Road Medical, Inc | 84.63 Million USD | 99.782% |